Jacobson Pharma Corporation Ltd
HKEX:2633
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.09
1.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| HK |
J
|
Jacobson Pharma Corporation Ltd
HKEX:2633
|
2.5B HKD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
538.2B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
279.1B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.8B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.2B CHF |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
267.5B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
149.5B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
97.4B EUR |
Loading...
|
Market Distribution
| Min | -239 513 300% |
| 30th Percentile | -12.9% |
| Median | 0.5% |
| 70th Percentile | 5.3% |
| Max | 203 056% |
Other Profitability Ratios
Jacobson Pharma Corporation Ltd
Glance View
Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors. The company employs 1,723 full-time employees The company went IPO on 2016-09-21. The firm runs its business via two segments. Generic Drugs segment develops, manufactures and distributes a host of off-patent medicine for various therapeutic uses. Currently the activities in this regard are primarily carried out in Hong Kong. Proprietary Chinese Medicines segment develops, manufactures and distributes Chinese medicines. Currently the activities in this regard are primarily carried out in Hong Kong.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Jacobson Pharma Corporation Ltd is 19.7%, which is above its 3-year median of 18.7%.
Over the last 3 years, Jacobson Pharma Corporation Ltd’s Net Margin has increased from 12.6% to 19.7%. During this period, it reached a low of 12.6% on Sep 30, 2022 and a high of 19.8% on Mar 31, 2023.